Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Transitional Cell 29 Carcinoma, Non-Small-Cell Lung 29 Urinary Bladder Neoplasms 26 Neoplasms 22 Carcinoma, Renal Cell 22 Carcinoma, Merkel Cell 21 Neoplasm Metastasis 18 Colorectal Neoplasms 16 Breast Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 15 Ovarian Neoplasms 14 Triple Negative Breast Neoplasms 11 Pancreatic Neoplasms 9 Melanoma 9 Head and Neck Neoplasms 8 Stomach Neoplasms 7 Recurrence 6 Carcinoma, Hepatocellular 6 Ureteral Neoplasms 5 Small Cell Lung Carcinoma 5 Prostatic Neoplasms 5 Urethral Neoplasms 4 Sarcoma 4 Neuroendocrine Tumors 4 Leukemia, Myeloid, Acute 4 Glioblastoma 4 Carcinoma, Squamous Cell 4 Uterine Cervical Neoplasms 3 Turcot syndrome 3 Skin Neoplasms 3

Interventions

Rituximab 112 Cyclophosphamide 103 fludarabine 61 Doxorubicin 33 Vincristine 31 Etoposide 31 Prednisone 30 Lenalidomide 24 ibrutinib 22 fludarabine phosphate 21 Immunotherapy, Adoptive 19 Bendamustine Hydrochloride 19 obinutuzumab 18 Cytarabine 18 pembrolizumab 16 Magnetic Resonance Spectroscopy 16 Bortezomib 14 Specimen Handling 13 Dexamethasone 13 polatuzumab vedotin 12 CT-P10 12 venetoclax 11 pirtobrutinib 11 Gemcitabine 11 Carboplatin 11 glofitamab 10 zanubrutinib 9 Nivolumab 9 Mycophenolic Acid 9 Melphalan 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × avelumab × Clear all

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡